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Summary P-cadherin (P-CD) and E-cadherin (E-CD) are expressed by keratinocytes and play an important
role in skin morphogenesis. P-CD expression is restricted to the basal layer of normal epidermis, whereas
E-CD is expressed in all the living layers. We have previously reported a reduced expression of E-CD in most
cases of infiltrative basal cell carcinoma (BCC). In the present work we have investigated by immunohis-
tochemistry the expression of both P-CD and E-CD in a new series of 32 patients with BCC. Most cases of
superficial multicentric BCC and some nodular tumours had preserved expression of both cadherins in all
tumour cells. The majority of nodular BCCs had partially reduced expression of one or both cadherins with an
ordered distribution of cells showing different cadherin staining throughout the tumour mass. A severe
reduction of E-CD expression with a disordered distribution of cells with different immunostaining intensity
was observed in most specimens of infiltrative BCC. In contrast, P-CD expression was preserved in all cases of
infiltrative BCC. These results suggest that P-CD and E-CD play different roles in the growth pattern of BCC.
In addition, both anomalous P-CD expression and reduced E-CD expression were frequently observed in the
spinous layer of epidermis overlying tumours. This phenomenon was significantly associated with the presence
of keratinocytic atypia, which suggests that disturbed cadherin expression could be a marker of premalignant
changes and/or hyperproliferative activity in human epidermis.
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Placental (P) and epithelial (E) cadherins (CDs) are calcium-
dependent cell-cell adhesion molecules which usually medi-
ate homophilic and homotypic adhesion between cells in
contact (Takeichi, 1991). At the cellular level, both cadherins
are preferentially concentrated in the adherens type of
intercellular junctions. Intracellularly, they interact with
several proteins, collectively termed catenins, which link the
cadherin to the actin-based cytoskeleton (Grunwald, 1993).
In cells coexpressing both cadherins, such as the human
squamous carcinoma cell line A-431, P- and E-CD appear to
be present in separate cadherin-catenin complexes (Johnson
et al., 1993). In normal mouse and human epidermis, P-CD
is detected on the cell-cell contact surface of basal
keratinocytes, but as cells migrate into the suprabasal com-
partment they down-regulate P-CD expression. P-CD is also
expressed in the outer root sheath and the hair matrix of the
hair follicle (Nose and Takeichi, 1986; Shimoyama et al.,
1989; Fujita et al., 1992). In contrast, E-CD is expressed on
the cell surface of keratinocytes in all the living layers of the
epidermis, but E-CD immunostaining is stronger in the
spinous layer than in the basal layer. E-CD expression is also
detected in both the outer and inner portions of hair follicles
during hair development (Shimoyama et al., 1989; Fujita et
al., 1992). There is experimental evidence that both cadherins
play an important role in the morphogenesis of epidermis
and skin appendages (Hirai et al., 1989; Wheelock and
Jensen, 1992; Lewis et al., 1994).
Experimental studies in several tumour cell lines and
pathological observations in experimental and human car-
cinomas have suggested a role for E-CD in invasiveness and
differentiation of carcinoma cells (for review, see Takeichi,
1993; Birchmeier and Behrens, 1994; Mareel et al., 1994).
The loss of E-CD expression and/or functional inactivation
of the cadherin-catenin complex seems to be related with
dedifferentiation and acquisition of the invasive phenotype by
tumour cells. In addition, tumorigenicity is increased in
transformed keratinocyte cell lines which display low levels of
E-CD (Navarro et al., 1991). The role of P-CD expression in
tumour biology has been less investigated. Studies on P-CD
expression in cell lines derived from mouse skin car-
cinogenesis led us to suggest that P-CD may contribute to
the maintenance of the epithelial phenotype and may be
involved, together with E-CD, in the final stage of tumour
progression in epidermal carcinogenesis, since both cadherins
were absent in spindle cell carcinomas (Navarro et al., 1991).
To date, the few studies reported on P-CD expression in
human carcinomas have shown conflicting results which seem
to be related, at least in part, with the type of tissue origin of
the tumours (Shimoyama et al., 1989; Shimoyama and
Hirohashi, 1991; Rasbridge et al., 1993; Yasui et al., 1993;
Sakaki et al., 1994). For example, reduced P-CD expression
seems to correlate with tumour progression in gastric (Yasui
et al., 1993) and gingival carcinomas (Sakaki et al., 1994). In
contrast, P-CD expression was higher in poorly differentiated
than in well-differentiated lung carcinomas (Shimoyama et
al., 1989).
Basal cell carcinoma (BCC) is the most common malignant
tumour of the skin (Miller, 1991a). Despite numerous
previous investigations, consensus concerning the origin and
differentiation of this tumour is still lacking. Most theories
propose that BCC arises from a progenitor stem cell either
from the basal layer of the epidermis or from adnexal struc-
tures (Grimwood et al., 1986; Miller, 1991b). Some BCCs
may differentiate toward follicular, sebaceous, apocrine or
eccrine structures (Wade and Ackerman, 1978; Lever and
Schaumburg-Lever, 1990). Thus, BCC is considered to be a
neoplasm composed of usually undifferentiated yet quite
pluripotential germinative cells. Based on the overall growth
pattern, the tumours may be classified in three main groups:
superficial multicentric, nodular expansive, and infiltrative
(Sloane, 1977). This classification is clearly of value and has
important pathological and clinical implications. Tumours
growing with an infiltrative growth pattern have increased
local aggressiveness and tendency to recurrence after treat-
ment, and frequently invade the deeper structures beneath
the skin (Sloane, 1977; Jacobs et al., 1982; Leffel et al., 1991).
We have previously reported that E-CD expression was pre-
served in cases of superficial and nodular BCC, and was
reduced in most cases of infiltrative BCC, suggesting a role
for E-CD in the growth pattern and local invasiveness of
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BCC (Pizarro et al., 1994). In another study, preserved E-CD
expression in the outer cell layers of the tumour nests was
also found in five nodular BCCs (Czech et al., 1993).
In the present work, we have investigated by immunohis-
tochemistry the expression of both P- and E-CD in a new
series of BCCs of skin in order to correlate cadherin expres-
sion with the cytoarchitecture and overall growth pattern of
the tumours. We have also examined cadherin expression in
the epidermis overlying tumours because previous studies
have demonstrated that this epidermis differs from normal
epidermis with regard to some biological properties, such as
keratin typing and proliferative activity (Kikuchi et al.,
1993).
Materials and methods
Tissue specimens
Thirty-two primary untreated BCCs, each from a different
patient, were surgically removed and the diagnosis confirmed
by histopathology. There were 17 men and 15 women with a
mean age of 69.3 years (range 49-89). Twenty-five lesions
were located on the face and seven lesions were located on
the trunk. Tumours included in this series were classified in
three different patterns ofgrowth: superficial multicentric (i.e.
tumour nests attached to the undersurface epidermis, with a
well-demarcating peripheral palisading, seven samples); nod-
ular expansive (i.e. tumour nests of various shapes and sizes
embedded in the dermis, with a rounded smooth outline and
well-developed palisading, 14 samples); and infiltrative (i.e.
small cell nests and aggregates with spiky irregular
configuration and absent or poorly developed peripheral
palisading, 11 samples). Keratinocytic atypia in the epidermis
overlying lesions (i.e. basal and/or suprabasal keratinocytes
with disturbed cellular polarity and irregular, enlarged nuclei
with conspicuous, sometimes multiple, darkly stained nuc-
leoli) was observed in 16 cases. Normal human skin was
obtained from cosmetic surgery procedures. Tumour tissue
and normal skin obtained from fresh specimens were embed-
ded in optimal cryopreserving tissue (OCT) compound (Miles
Laboratory, Naperville, IL, USA), snap frozen in liquid
nitrogen-cooled isopentane and stored at - 70°C. The
remaining tumour tissue was routinely fixed in 10% formalin
for 24 h and embedded in paraffin.
Antibodies
Two mouse monoclonal antibodies specific for human P-CD
(NCC-CAD-299) and human E-CD (HECD-1) (Shimoyama
et al., 1989) were used. Both monoclonal antibodies were
kindly provided by Professor M Takeichi (Department of
Biophysics, Faculty of Science, Kyoto University, Japan).
Cadherin expression by immunohistochemical technique
Immunostaining was performed by the streptavidin-bio-
tin-alkaline phosphatase method as previously reported
(Gamallo et al., 1993; Pizarro et al., 1994), with some
modifications. Briefly, cryostat sections of 5-6glm thickness
were cut, air dried for 15 min, fixed in 10% formalin in Tris
buffer containing 10 mM Ca2", pH 7.2, for 3 min, and then
post-fixed in methanol at -10°C for 1 min and in acetone at
4°C for 3 min. After washing, non-specific binding was
blocked with 5% non-fat milk, 0.1% Triton x -100 (Sigma,
St Louis, MO, USA) for 30 min at room temperature. The
slides were incubated with the MAbs NCC-CAD-299 and
HECD-1 for 1 h at 37°C in a humidified chamber. The
primary antibodies were used at a dilution of 1:20 and 1:200
respectively, made in 150 mM sodium chloride, 10 mM Hepes
pH 7.4, 10 mm calcium chloride (HMC-Ca buffer), contain-
ing 1% (w/v) bovine serum albumin (BSA). After washing in
Tris buffer pH 7.4 with 10 mM Ca2 , the sections were
incubated with biotinylated goat anti-mouse IgG (Biomakor,
Rehovot, Israel) diluted 1:200 for 30 min at 37°C, followed
by a 30 min incubation with a 1:250 dilution of strep-
tavidin-alkaline phosphatase complex (Dako, Glostrup,
Denmark) at 37°C. Dilution of both the secondary antibody
and the streptavidin-alkaline phosphatase complex was
made in Tris buffer-1% bovine serum albumin (BSA). The
alkaline phosphatase activity was developed using naphthol
AS-MX phosphate (Sigma) as substrate and fast red dye
(Sigma) as the chromogen group. Sections were finally
counterstained with Meyer haematoxylin and mounted for
light microscopic study. Negative controls consisted of sec-
tions of each tumour in which the primary antibody was
replaced by an irrelevant mouse monoclonal antibody of the
same isotype. Normal human skin was used as a positive
control.
Evaluation ofthe immunohistochemical staining
Staining for each cadherin was evaluated separately in both
the outer and the inner cell layers of the tumour nests in each
specimen in order to correlate the intensity and distribution
of cadherin expression with the cytoarchitecture and growth
pattern of the tumours. Preserved cadherin expression im-
plied strong or moderate staining intensity in the majority of
cells. Reduced cadherin expression was c6nsidered when most
cells were weakly or negatively stained, either in the
periphery or in the central part of tumour nests (partially
reduced cadherin expression) or in both (globally reduced
cadherin expression).
Regarding cadherin expression in the overlying epidermis,
P-CD was considered to be normally expressed when it was
restricted to the basal layer. The expansion of the P-CD
positive cells in the spinous layer was defined as anomalous
P-CD expression. On the other hand, reduced E-CD expres-
sion implied that the intensity of immunostaining in the
spinous layer was weaker than that observed in normal
epidermis.
Statistical analysis
The chi-square test was used to analyse the statistical
significance between cadherin expression in the tumours and
the growth pattern, as well as between cadherin expression in
the overlying epidermis and the presence of keratinocytic
atypia, the location of the tumours and their growth pattern.
Results
Cadherin expression in BCC
The expression of P- and E-CD in different histological types
of BCC is summarised in Table I. Both cadherins were
expressed in all specimens with variable intensity and dis-
tribution, showing a linear pattern around the periphery of
tumour cells. Weak cytoplasmic staining was occasionally
noted.
Table I Cadherin expression in different histological types of BCC
P-cadherin E-cadherin
Growth pattern OCL ICL OCL ICL No. ofcases
Superficial Pre Pre Pre Pre 5
Pre Pre Red Pre 2
Nodular Pre Red Red Pre 4
Pre Pre Pre Pre 3
Pre Red Pre Pre 3
Pre Pre Red Pre 3
Pre Pre Pre Red 1
Infiltrative Pre Pre Red Red 9
Pre Pre Pre Pre 2
OCL, outer cell layers; ICL, inner cell layers; Pre, preserved; Red,
reduced.Five of seven (71%) cases of superficial multicentric BCC
showed preserved expression of the two cadherins in both the
outer and the inner cell layers of the tumour nests (Figure la
and b). The remaining two cases showed preserved P-CD
expression throughout the tumour mass, whereas E-CD
staining was preserved in the central part of the tumour nests
but reduced in the outer cell layers.
Only three out of 14 (21%) cases of nodular BCC showed
preserved expression of both cadherins in all the tumour
cells. In the remaining 11 cases (79%) the pattern ofcadherin
expression was highly variable, as indicated in Table I. It is
noteworthy that all nodular BCCs have preserved P-CD
expression in the outer cell layers of the tumour nests. How-
ever, seven cases (50%) showed reduced P-CD expression in
the inner cell layers. Eight out of 14 (57%) specimens showed
reduced E-CD expression, either in the periphery (seven
cases) or the central part (one case) of the tumour nests.
Four cases with histopathological signs of limited follicular
P- and E-cadherin in BCC
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differentiation had a similar pattern of cadherin expression,
showing preserved P-CD/reduced E-CD expression in the
outer cell layers, but reduced P-CD/preserved E-CD expres-
sion in the inner cell layers (Figure lc and d).
Preserved P-CD expression throughout the tumour mass
was detected in all cases of infiltrative BCC (Figure le). In
contrast, nine out of 11 (78%) infiltrative BCCs showed
reduced E-CD staining in both the periphery and central part
of the tumour nests (globally reduced E-CD expression).
Among them, immunostaining was homogeneously reduced
(very weak or even absent) in almost all the tumour cells in
two cases (Figure If). In the remaining seven cases the cells
showing different immunostaining intensity were intermingled
in tumour nests without any definite spatial distribution, the
cells with weak or negative staining being more abundant.
Strong immunostaining for E-CD was focally observed in
some cases in cellular aggregates showing squamous differ-
entiation and horn pearls formation (Figure If). The statis-
Figure 1 Immunostaining for P-cadherin (a, c and e) and E-cadherin (b, d and f) in different histological types of basal cell
carcinoma (BCC). Superficial BCC with preserved expression of P-CD (a) and E-CD (b). Nodular BCC, with preserved expression
of P-CD in the outer cell layers (c) and preserved expression of E-CD in the central part of tumour nests (d). Infiltrative BCC
showing preserved expression of P-CD (e) and very weak or even absent E-CD immunostaining (f) in almost all tumour cells. Note
the strong E-CD staining in a cellular aggregate with squamous differentiation and horn pearl formation (f, arrowheads).
MR-P.P- and E-cadherin in BCC
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tical analysis showed a significant association between the
infiltrative growth pattern and globally reduced E-CD ex-
pression (P<0.01), as well as between partially reduced
P-CD expression (always in the central part of tumour nests)
and the nodular growth pattern (P<0.01).
Cadherin expression in the epidermis overlying tumours
Results are summarised in Table II. Twelve out of 32 cases
(36%) showed normal expression of both cadherins in the
epidermis overlying tumours. Eleven of these cases (92%)
had no histopathological signs of keratinocytic atypia.
Twenty out of 32 cases (64%) showed anomalous P-CD
expression, which was observed in both basal and suprabasal
Table II Cadherin expression in epidermis overlying tumours:
correlation with the presence of keratinocytic atypia, location of the
lesions and their growth pattern
Cadherin expression
Normal P-CD Anomalous P-CD Anomalous P-CD
Normal E-CD Normal E-CD Reduced E-CD
Keratinocytic
atypia
Absent 11 3 2
Present 1 7 8
Location
Face 10 8 7
Trunk 2 2 3
Growth pattern
Superficial 3 3 1
Nodular 6 4 4
Infiltrative 3 3 5
keratinocytes (Figure 2a). Among them, ten cases had nor-
mal E-CD expression and the remaining ten cases had
reduced E-CD expression (Figure 2b). Epidermis distal from
the tumours had a normal pattern of cadherin expression
(Figure 2c and d), and disturbed cadherin expression
becomes progressively more pronounced with increasing pro-
ximity to tumour tissue. The statistical analysis showed a
significant association between the presence of keratinocytic
atypia and both anomalous P-CD expression (P<0.01) and
reduced E-CD expression (P = 0.05). In contrast, neither
tumour location nor the histological type of BCC appear to
be significantly associated with disturbed cadherin expression
in the overlying epidermis.
Discussion
BCC of the skin is a low-grade tumour with a low potential
for metastasis but with a significant risk of local invasion,
destruction and recurrence. Many factors seem to be im-
plicated in the local aggressiveness and growth pattern of
BCC, such as the integrity and composition of the basement
membrane zone, the release of proteases implicated in the
extracellular matrix degradation and the expression ofcell-to-
substrate and cell-to-cell adhesion molecules, such as integ-
rins and cadherins (Miller, 1991a; Stamp and Pignatelli,
1991; Pizarro et al., 1994).
We have previously reported preserved E-CD expression in
almost all tumour cells in cases of superficial and nodular
BCC of skin (Pizarro et al., 1994). In the present series, we
have observed that many cases of nodular BCC and some
cases of superficial BCC had partially reduced E-CD expres-
sion, being composed of two populations of cells with
different E-CD immunostaining. It is noteworthy that, in
Figure 2 Immunostaining for P-cadherin (a and c) and E-cadherin (b and d) in the epidermis overlying a basal cell carcinoma (a
and b) and in the normal epidermis distal to the tumour (c and d). Strong P-CD (a) and weak E-CD staining (b) is detected in the
spinous layer of epidermis adjacent to tumour. In contrast, P-CD expression is restricted to the basal layer of both epidermis (c)
and adnexal structures (c, arrowheads) in the skin distal to the tumours. Strong E-CD staining is observed in the spinous layer of
the distal epidermis (d).P- and E-cadherin in BCC
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these tumours, cells showing a similar amount of E-CD tend
to be grouped. A similar finding was also reported by Czech
et al. (1993). Thus, a relatively complex picture seems to
emerge from the various studies on E-CD expression in
specimens of nodular and superficial BCC. There are three
main patterns of E-CD expression in these tumours: (1)
preserved expression throughout the tumour mass; (2) pre-
served expression in the outer cell layers and reduced expres-
sion in the inner ones; and (3) reduced expression in the
outer cell layers and preserved expression in the central part
of the tumour nests. In contrast, E-CD expression was
reduced in most cases of infiltrative BCC, both in the
periphery and in the central part of tumour nests (globally
reduced E-CD expression). These cases showed either a weak
or even absent E-CD immunoreactivity in most tumour cells
or a mixed population of cells showing different E-CD stain-
ing intensity without any definite spatial distribution
throughout the tumour mass. All these observations suggest
that both the intensity and the topography of E-CD expres-
sion may be related to the overall growth pattern of the
tumours and that an ordered pattern of E-CD expression, as
observed in superficial and nodular BCCs, may be related to
reduced invasiveness. In contrast, globally reduced E-CD
expression and a disordered distribution of cells with
different E-CD staining may favour the infiltrative growth
pattern.
The expression of P-CD in tumour cells of BCC was
expected, since P-CD is present in basal cells of both normal
epidermis and hair follicles (Shimoyama et al., 1989; Fujita et
al., 1992). P-CD expression was preserved in the outer cell
layers of tumour nests in all specimens without exception.
However, some cases of nodular BCC showed reduced P-CD
expression in the central part of tumour nests which could be
related with the state of differentiation of these cells, since
P-CD expression is down-regulated in both suprabasal
keratinocytes of the epidermis and the inner root sheath of
embryonic hair follicles (Nose and Takeichi, 1986; Hirai et
al., 1989; Fujita et al., 1992). Furthermore, several different
patterns of P- and E-CD expression were observed in
superficial and particularly in nodular BCC when we
examined both cadherins together. This diversity could be the
result ofthe pluripotential nature of the cell oforigin of BCC
and could be related in part to the degree of differentiation
of tumour cells either towards epidermis or adnexal struc-
tures. Interestingly, four nodular BCC showing histological
signs of limited follicular differentiation displayed the same
pattern of cadherin expression, resembling in part that
observed in hair bulbs during hair development (Fujita et al.,
1992; Kaplan and Holbrook, 1994).
A relevant finding of this study is that all the infiltrative
tumours analysed showed preserved P-CD expression in
almost all the tumour cells, which is in contrast to the
reduced E-CD expression usually observed in this type of
BCC. It strongly suggests that P-CD expression does not
prevent local invasiveness and aggressive behaviour of BCC.
In this sense, it should be pointed out that experimental
observations in cell lines coexpressing both cadherins seem to
support that cell-cell interactions mediated by P-CD may be
more unstable than those mediated by E-CD (Wu et al.,
1993). A role for P-CD in less permanent cell-cell associa-
tions is also consistent with the restricted expression of this
cadherin to basal proliferating cells of stratified epithelia,
where their cell-cell contacts must be frequently broken and
reformed (Nose and Takeichi, 1986; Shimoyama et al., 1989).
Thus, it is conceivable that preserved P-CD expression
together with reduced E-CD expression throughout the
tumour mass may reduce cohesiveness between tumour cells
and may favour the infiltrative growth pattern. However,
P-CD expression may contribute to the maintenance of the
basaloid epithelial phenotype in tumour cells with severely
reduced or even absent E-CD expression.
Particularly interesting is the finding that anomalous P-CD
expression was frequently observed in the spinous layer of
epidermis overlying tumours. In addition, some of these cases
also showed reduced E-CD expression. This is in line with
previous observations showing several biological abnor-
malities, such as increased proliferative activity and abnormal
expression of keratins, involucrin, transforming growth fac-
tor beta and epidermal growth factor receptor, in the epider-
mis adjacent to BCC (Said et al., 1984; Asada et al., 1993;
Kikuchi et al., 1993; Stamp et al., 1993). It has been sug-
gested that diffusible factors elaborated by malignant cells
and/or activated dermal cells could interfere with the normal
differentiation of adjacent normal cells, causing altered ex-
pression of several antigens in non-neoplastic keratinocytes
adjacent to tumours (Wolf and Bystryn, 1981). The
inflammatory response to the tumour tissue or to ulceration
could play some role in this phenomenon. Thus, it would be
of interest to investigate further whether cytokines and
growth factors modulate cadherin expression in epidermal
keratinocytes. Alternatively, abnormalities in the overlying
epidermis may reflect field cancerisation of the skin (Kikuchi
et al., 1993). In fact, our observation that disturbed cadherin
expression was significantly associated with the presence of
keratinocytic atypia suggests that it could be an early indica-
tion of malignant transformation.
In summary, our results suggest that the patterns of ex-
pression of P- and E-CD are related, at least in part, with the
cytoarchitecture of BCC, and that P- and E-CD must play
different roles in the growth pattern and local invasiveness of
BCC. In particular, preserved P-CD expression together with
severely reduced E-CD expression throughout the tumour
mass may favour the locally aggressive behaviour of BCC. In
addition, disturbed cadherin expression is frequently found in
the overlying epidermis and could be a biological marker for
a hyperproliferative state and/or premalignant changes in
human epidermis.
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